Retatrutide (LY-3437943) is a first-in-class triple agonist peptide that simultaneously activates GIP, GLP-1, and glucagon receptors.
Retatrutide
NewPrice range: $34.99 through $59.99
Description
Retatrutide (LY-3437943) is a first-in-class triple agonist peptide that simultaneously activates GIP, GLP-1, and glucagon receptors.
Related products
-
New
Select options This product has multiple variants. The options may be chosen on the product page Quick ViewPrice range: $39.99 through $54.99Tirzepatide (LY3298176) is a dual GIP and GLP-1 receptor agonist developed for metabolic research.
Select options This product has multiple variants. The options may be chosen on the product page -
New
- 50 % Off Select options This product has multiple variants. The options may be chosen on the product page Quick ViewPrice range: $34.99 through $54.99Semaglutide is a long-acting GLP-1 receptor agonist with extensive characterization in incretin research
Select options This product has multiple variants. The options may be chosen on the product page